Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study

• Type of Material: Article
• Authors: Valerie J. Flaherman, University of California San Francisco; Yalda Afshar, University of California Los Angeles; W. John Boscardin, University of California San Francisco; Roberta L. Keller, University of California San Francisco; Anne H. Mardy, University of California San Francisco; Mary K. Prahl, University of California San Francisco; Carolyn T. Phillips, University of California San Francisco; Ifeyinwa V. Asiodu, University of California San Francisco; Vincenzo Berghella, Thomas Jefferson University; Brittany D. Chambers, University of California San Francisco; Joia Crear-Perry, National Birth Equity Collaborative; Denise Jamieson, Emory University; Vanessa L. Jacoby, University of California San Francisco; Stephanie L. Gaw, University of California San Francisco
• Language: English
• Date: 2021-11-02
• Publisher: OXFORD UNIV PRESS INC
• Publication Version: Final Published Version
• Copyright Statement: © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1093/cid/ciaa1411
• Title of Journal or Parent Work: CLINICAL INFECTIOUS DISEASES
• Volume: 73
• Issue: 9
• Start Page: E2810
• End Page: E2813
• Grant/Funding Information: This work was supported by the University of California San Francisco National Center of Excellence in Women’s Health; California Health Care Foundation; the Centers for Disease Control and Prevention Foundation; the Bill and Melinda Gates Foundation; and individuals that provided support through 2 crowdfunding sites (https://givingtogether.ucsf.edu/fundraiser/2718761 and https://spark.ucla.edu/project/20775).
• Keywords: newborn; Science & Technology; COVID-19; Microbiology; Infectious Diseases; pregnancy; SARS-CoV-2; Immunology; Life Sciences & Biomedicine
• Research Categories: Health Sciences, Obstetrics and Gynecology; Health Sciences, Public Health; Biology, Microbiology; Health Sciences, Immunology; Biology, Virology

Abstract

Infant outcomes after maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not well described. In a prospective US registry of 263 infants, maternal SARS-CoV-2 status was not associated with birth weight, difficulty breathing, apnea, or upper or lower respiratory infection through 8 weeks of age.